Form 4: Incyte EVP Christiana Stamoulis Reports Acquisition of Common Stock from Performance Shares
SEC Form 4 Filing
Christiana Stamoulis, EVP & Chief Financial Officer of Incyte Corp, reports the acquisition of common stock related to performance shares, increasing her beneficial ownership.
Summary
- Christiana Stamoulis, the EVP & Chief Financial Officer of Incyte Corp, filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 18,598 shares of common stock on April 1, 2025, related to performance shares earned based on Opzelura performance goals.
- These shares will vest on November 30, 2025, contingent upon continued service with Incyte.
- Additionally, 18,970 shares were acquired on the same date, linked to performance shares earned based on development, revenue, and market-based performance goals.
- These shares will vest on July 2, 2025, the third anniversary of the grant date, also subject to continued service.
- The total number of shares beneficially owned following these transactions is 129,093.
- This includes 84,321 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as it reflects the achievement of performance goals and continued alignment of executive interests with the company's success. However, it's a routine filing and doesn't contain groundbreaking news.
Positives
- The acquisition of shares indicates that performance criteria related to Opzelura, development, revenue, and market-based goals were met.
- The vesting of these shares is tied to continued service, aligning the executive's interests with the company's long-term success.
Risks
- The vesting of the acquired shares is contingent upon the Reporting Person's continued service with the Issuer.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting of shares is tied to continued service and achievement of performance goals, suggesting an expectation of continued contributions from the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates that performance goals were met, which could be viewed positively by investors.
Stakeholder Impact
- Shareholders may view the acquisition of shares positively as it indicates the achievement of performance goals.
- The vesting of shares contingent on continued service aligns the executive's interests with the company's long-term success, which can be reassuring to stakeholders.
Key Dates
| Date | Description |
|---|---|
| July 2, 2022 | Grant date of performance shares that vest on the third anniversary. |
| April 1, 2025 | Date of transaction for acquisition of common stock related to performance shares. |
| April 3, 2025 | Date of signature on the Form 4 filing. |
| November 30, 2025 | Vesting date for shares earned based on Opzelura performance goals. |
Keywords
Incyte, Stamoulis, Beneficial Ownership, Form 4, Performance Shares, Opzelura, RSUs, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.